Strides Pharma Science Limited — Important, 03-07-2026: Sale or disposal
03-07-2026 | 05:50 pm
03-07-2026 | 05:50 pm
Strides Pharma completed its majority stake sale in Pivot Path to an Ascent Capital-led consortium for ₹100 Cr. The company received ₹75 Cr, with ₹25 Cr due in a year. Pivot Path is now an Associate Company.
No comments yet. Be the first to comment!
